Setting A Science Agenda For The Presidential Candidates

Are science and technology being shortchanged in the current presidential race? So far, the campaign has focused on past policies and mistakes, not future directions. The talk about tomorrow has been nothing more than stirring rhetoric about making the United States great again, bringing it back, and other equally vague promises. Missing is any specific debate about science and technology (see The Scientist, June 27, 1988, page 1). Both George Bush and Michael Dukakis are “for” t

Written byJonathan Coopersmith
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Are science and technology being shortchanged in the current presidential race? So far, the campaign has focused on past policies and mistakes, not future directions. The talk about tomorrow has been nothing more than stirring rhetoric about making the United States great again, bringing it back, and other equally vague promises.

Missing is any specific debate about science and technology (see The Scientist, June 27, 1988, page 1). Both George Bush and Michael Dukakis are “for” them, but which technology or science do they favor, and what exactly will they do? The point is not trivial.

The decisions made by the government in the next few years will shape our lives beyond the year 2000. Listed below are some issues that the Congress and next president should think about. If we don’t act on these issues soon, they will turn from hypothetical possibilities to real crises. The key questions are:

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies